{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:56:40Z","timestamp":1793660200905,"version":"4.5.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Y008448\/1"],"award-info":[{"award-number":["MR\/Y008448\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejso.2024.108740","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T21:47:15Z","timestamp":1728078435000},"page":"108740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment strategies with electrochemotherapy for limb in-transit melanoma: Real-world outcomes from a European, retrospective, cohort study"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8466-8459","authenticated-orcid":false,"given":"Luca G.","family":"Campana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tauceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"B\u00e1rtolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6887-4404","authenticated-orcid":false,"given":"Joy","family":"Odili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-5404","authenticated-orcid":false,"given":"Giulia","family":"Carrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Farricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Piazzalunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriszta","family":"Botty\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Bisarya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2036-8721","authenticated-orcid":false,"given":"Matteo","family":"Mascherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1309-837X","authenticated-orcid":false,"given":"James A.","family":"Clover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7892-4444","authenticated-orcid":false,"given":"Serena","family":"Sestini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7288-6582","authenticated-orcid":false,"given":"Ma\u0161a","family":"Bo\u0161njak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Kis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Fantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Covarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Brizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cabula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Careri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Fabrizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-9964","authenticated-orcid":false,"given":"Klaus","family":"Eisendle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7299-8656","authenticated-orcid":false,"given":"Alastair","family":"MacKenzie Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadrian","family":"Schepler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Borgognoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7641-5670","authenticated-orcid":false,"given":"Gregor","family":"Sersa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Valpione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2024.108740_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1245\/s10434-014-4100-0","article-title":"In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy","volume":"22","author":"Read","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1245\/ASO.2005.05.025","article-title":"Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy","volume":"12","author":"Pawlik","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1245\/s10434-019-07760-7","article-title":"The landmark series: regional therapy of recurrent cutaneous melanoma","volume":"27","author":"Beasley","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1200\/JOP.18.00063","article-title":"Contemporary approaches to in-transit melanoma","volume":"14","author":"Perone","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.ejso.2024.108740_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10585-021-10100-3","article-title":"In-transit metastatic cutaneous melanoma: current management and future directions","volume":"39","author":"Patel","year":"2022","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ejso.2024.108740_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.soc.2014.12.008","article-title":"Regional therapies for in-transit disease","volume":"24","author":"Speicher","year":"2015","journal-title":"Surg Oncol Clin"},{"key":"10.1016\/j.ejso.2024.108740_bib7","first-page":"246","article-title":"Local and regional therapy for primary and locally recurrent melanoma","volume":"19","author":"Wilkes","year":"2021","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/jso.26121","article-title":"Lesional therapies for in-transit melanoma","volume":"122","author":"Nadler","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000440","article-title":"Efficacy of immune checkpoint inhibitors for in-transit melanoma","volume":"8","author":"Nan Tie","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2022.03.041","article-title":"The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases \u2013 a multicenter cohort study","volume":"169","author":"Holmberg","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41591-023-02336-1","article-title":"Neoadjuvant immunotherapy for melanoma is now ready for clinical practice","volume":"29","author":"Garbe","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2024.108740_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2023.01.004","article-title":"Neo-adjuvant immunotherapy emerges as best medical practice and will be the new standard of care for macroscopic stage III melanoma","volume":"182","author":"van Akkoi","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2021.04.032","article-title":"Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases","volume":"152","author":"Zaremba","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41591-020-01188-3","article-title":"Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)","volume":"27","author":"Menzies","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2024.108740_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejca.2021.02.012","article-title":"Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma","volume":"148","author":"Versluis","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejca.2021.04.003","article-title":"The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: a multicentre retrospective analysis","volume":"151","author":"Versluis","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib17","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2014.55.4634","article-title":"Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis","volume":"32","author":"Spratt","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/0284186X.2021.2006776","article-title":"Impact of electrochemotherapy in metastatic cutaneous melanoma: a contemporary systematic review and meta-analysis","volume":"61","author":"Petrelli","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejca.2020.06.020","volume":"138","author":"Clover","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib20","doi-asserted-by":"crossref","DOI":"10.2217\/mmt-2021-0006","article-title":"Successful electrochemotherapy treatment of a large bleeding lymph node melanoma metastasis","volume":"9","author":"Landstr\u00f6m","year":"2022","journal-title":"Melanoma Manag"},{"key":"10.1016\/j.ejso.2024.108740_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/030089160909500324","article-title":"Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy","volume":"95","author":"Snoj","year":"2009","journal-title":"Tumori"},{"key":"10.1016\/j.ejso.2024.108740_bib22","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ejso.2020.10.037","article-title":"Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: a matched cohort analysis from the InspECT registry","volume":"47","author":"Sersa","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib23","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/0284186X.2018.1454602","article-title":"Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases","volume":"57","author":"Gehl","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.seminoncol.2019.04.002","article-title":"Electrochemotherapy of superficial tumors \u2013 current status:: basic principles, operating procedures, shared indications, and emerging applications","volume":"46","author":"Campana","year":"2019","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib25","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/bjd.15340","article-title":"Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT","volume":"176","author":"Kunte","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejso.2024.108740_bib26","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1245\/s10434-008-9976-0","article-title":"Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases","volume":"15","author":"Quaglino","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/bjs.8749","article-title":"Electrochemotherapy for disseminated superficial metastases from malignant melanoma","volume":"99","author":"Campana","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2024.108740_bib28","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/1471-2407-13-564","article-title":"Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis","volume":"13","author":"Carac\u00f2","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib29","series-title":"Handbook of electroporation","first-page":"1","article-title":"International Network for sharing practices on electrochemotherapy (InspECT): an integrative patients treatment consortium","author":"Brizio","year":"2016"},{"key":"10.1016\/j.ejso.2024.108740_bib30","first-page":"472","article-title":"Melanoma staging: evidence\u2010based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2024.108740_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib32","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1245\/s10434-022-11997-0","article-title":"Clinicopathological characteristics predicting further recurrence and survival following resection of in-transit melanoma metastases","volume":"29","author":"Lawless","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib33","doi-asserted-by":"crossref","first-page":"8492","DOI":"10.1245\/s10434-022-12224-6","article-title":"Educational review: neoadjuvant approaches to melanoma","volume":"29","author":"Sharon","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib34","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/bjs\/znad105","article-title":"European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma","volume":"110","author":"Campana","year":"2023","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2024.108740_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/978-3-319-32886-7_4","article-title":"Electric field distribution and electroporation threshold","volume":"2","author":"Kranjc","year":"2017","journal-title":"Handbook Electro"},{"key":"10.1016\/j.ejso.2024.108740_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-201X.2003.01093.x","article-title":"Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research","volume":"177","author":"Gehl","year":"2003","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.ejso.2024.108740_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejcsup.2006.08.006","article-title":"Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy","volume":"4","author":"Miklavcic","year":"2006","journal-title":"Eur J Cancer Suppl"},{"key":"10.1016\/j.ejso.2024.108740_bib38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1054\/bjoc.2000.1625","article-title":"Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy","volume":"84","author":"Cemazar","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejso.2007.05.016","article-title":"Electrochemotherapy in treatment of tumours","volume":"34","author":"Sersa","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2147\/CCID.S115984","article-title":"Electrochemotherapy induces apoptotic death in melanoma metastases: a histologic and immunohistochemical investigation","volume":"9","author":"Bigi","year":"2016","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"10.1016\/j.ejso.2024.108740_bib41","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28131","article-title":"Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells","volume":"3","author":"Calvet","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejso.2024.108740_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2478\/raon-2020-0009","article-title":"Long term response of electrochemotherapy with reduced dose of bleomycin in elderly patients with head and neck non-melanoma skin cancer","volume":"54","author":"Jamsek","year":"2020","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib43","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/jdv.14708","article-title":"Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry","volume":"32","author":"Rotunno","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejso.2024.108740_bib44","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.ejso.2022.01.027","article-title":"Isolated limb perfusion for locally advanced melanoma in the immunotherapy era","volume":"48","author":"Davies","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174289","article-title":"Combination of pembrolizumab with electrochemotherapy in cutaneous metastases from melanoma: a comparative retrospective study from the inspect and Slovenian cancer registry","volume":"13","author":"Campana","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108740_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020472","article-title":"Effects of the introduction of modern immunotherapy on the outcome of isolated limb perfusion for melanoma in-transit metastases","volume":"15","author":"Holmberg","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108740_bib47","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00262-008-0462-0","article-title":"Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses","volume":"57","author":"Roux","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ejso.2024.108740_bib48","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4161\/onci.21991","article-title":"Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation","volume":"1","author":"Gerlini","year":"2012","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejso.2024.108740_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10585-012-9505-1","article-title":"Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy","volume":"30","author":"Gerlini","year":"2013","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ejso.2024.108740_bib50","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10585-016-9814-x","article-title":"CD4+FOXP3+ T regulatory cells decrease and CD3+CD8+ T cells recruitment in TILs from melanoma metastases after electrochemotherapy","volume":"33","author":"Di Gennaro","year":"2016","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ejso.2024.108740_bib51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/ijd.14314","article-title":"The use of electrochemotherapy in combination with immunotherapy in the treatment of metastatic melanoma: a focused review","volume":"58","author":"Goggins","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejso.2024.108740_bib52","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.ejso.2022.05.023","article-title":"Electrochemotherapy and immune interactions; A boost to the system?","volume":"48","author":"Bendix","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib53","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2402604","article-title":"Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma","author":"Blank","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2024.108740_bib54","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/0284186X.2017.1290274","article-title":"Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma\u2013a case report","volume":"56","author":"Falk","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib55","doi-asserted-by":"crossref","first-page":"369","DOI":"10.21037\/atm-2023-5","article-title":"Combination strategies incorporating oncolytic viruses and immune checkpoint inhibitors for advanced melanoma: what is the evidence?","volume":"11","author":"Wongariyapak","year":"2023","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ejso.2024.108740_bib56","article-title":"Efficacy of immune checkpoint inhibitors for in-transit melanoma","volume":"8","author":"Nan","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib57","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1111\/jdv.18456","article-title":"Health-related quality of life trajectories in melanoma patients after electrochemotherapy: real-world insights from the InspECT register","volume":"36","author":"Campana","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejso.2024.108740_bib58","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/CMR.0000000000000914","article-title":"Efficacy of topical diphencyprone for melanoma in-transit metastases: a systematic review and meta-analysis","volume":"33","author":"Pham","year":"2023","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2024.108740_bib59","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1245\/s10434-021-10910-5","article-title":"Talimogene laherparepvec (T-VEC) for the treatment of advanced locoregional melanoma after failure of immunotherapy: an international multi-institutional experience","volume":"29","author":"Carr","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib60","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1200\/JCO.22.00343","article-title":"Randomized, double-blind, placebo-controlled, global phase III trial of talimogene laherparepvec combined with pembrolizumab for advanced melanoma","volume":"41","author":"Chesney","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib61","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/s41591-021-01510-7","article-title":"Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB\u2013IVM1a melanoma: a randomized, open-label, phase 2 trial","volume":"27","author":"Dummer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2024.108740_bib62","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41591-018-0198-0","article-title":"Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma","volume":"24","author":"Blank","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2024.108740_bib63","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1200\/JCO.23.01136","article-title":"Systemic therapy for melanoma: ASCO guideline update","volume":"41","author":"Seth","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib64","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.annonc.2020.07.005","article-title":"ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee","volume":"31","author":"Michielin","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006947","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0","volume":"11","author":"Pavlick","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejso.2024.108740_bib66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/CMR.0000000000000719","article-title":"The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trials","volume":"31","author":"Olofsson Bagge","year":"2021","journal-title":"Melanoma Res"},{"issue":"Suppl 15","key":"10.1016\/j.ejso.2024.108740_bib67","article-title":"Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanoma","volume":"37","author":"Agarwala","year":"2019","journal-title":"J Clin Oncol"},{"issue":"Suppl 15","key":"10.1016\/j.ejso.2024.108740_bib68","article-title":"Safety and clinical activity of combining systemic ipilimumab with isolated limb infusion in patients with in-transit melanoma","volume":"32","author":"Ariyan","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108740_bib69","first-page":"396","article-title":"Talimogene laherparepvec and novel injectable oncolytic viruses in the management of metastatic melanoma","volume":"5","author":"Jenkins","year":"2021","journal-title":"J Transl Genet Genom"},{"key":"10.1016\/j.ejso.2024.108740_bib70","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.ejso.2021.03.229","article-title":"Biological factors of the tumour response to electrochemotherapy: review of the evidence and a research roadmap","volume":"47","author":"Sersa","year":"2021","journal-title":"Eur J Surg Oncol"}],"updated-by":[{"DOI":"10.1016\/j.ejso.2025.111158","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324007972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324007972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T04:48:09Z","timestamp":1765342089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324007972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0748798324007972"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108740","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment strategies with electrochemotherapy for limb in-transit melanoma: Real-world outcomes from a European, retrospective, cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108740"}}